Exploring biology with small organic molecules (original) (raw)

• Brenner, S. The genetics of Caenorhabditis elegans. Genetics 77, 71–94 (1974).
  CAS PubMed PubMed Central Google Scholar
• Hartwell, L. H. Twenty-five years of cell cycle genetics. Genetics 4, 975–80 (1991).
  Google Scholar
• Stockwell, B. R. Chemical genetics: ligand-based discovery of gene function. Nature Rev. Genet. 1, 116–25 (2000).
  Article CAS Google Scholar
• Stockwell, B. R. Frontiers in chemical genetics. Trends Biotechnol. 18, 449–455 (2000).
  Article CAS Google Scholar
• Stockwell, B. R. Chemical genetic screening approaches to neurobiology. Neuron 36, 559–562 (2002).
  Article CAS Google Scholar
• Schreiber, S. L. The small-molecule approach to biology: chemical genetics and diversity-oriented organic synthesis make possible the systematic exploration of biology. Chem. Eng. News 81, 51–61 (2003).
  Article Google Scholar
• Schreiber, S. L. Chemical genetics resulting from a passion for synthetic organic chemistry. Bioorg. Med. Chem. 6, 1127–1152 (1998).
  Article CAS Google Scholar
• Kuruvilla, F. G., Shamji, A. F., Sternson, S. M., Hergenrother, P. J. & Schreiber, S. L. Dissecting glucose signalling with diversity-oriented synthesis and small-molecule microarrays. Nature 416, 653–657 (2002).
  Article ADS CAS Google Scholar
• Hannon, G. J. RNA interference. Nature 418, 244–251 (2002).
  Article ADS CAS Google Scholar
• Moore, P. & Clayton, J. To affinity and beyond. Nature 426, 725–731 (2003).
  PubMed Google Scholar
• Schreiber, S. L. Target-oriented and diversity-oriented organic synthesis in drug discovery. Science 287, 1964–1969 (2000).
  Article ADS CAS Google Scholar
• Young, S. S. & Ge, N. Design of diversity and focused combinatorial libraries in drug discovery. Curr. Opin. Drug Discov. Dev. 7, 318–324 (2004).
  CAS Google Scholar
• Jimonet, P. & Jager, R. Strategies for designing GPCR-focused libraries and screening sets. Curr. Opin. Drug Discov. Dev. 7, 325–333 (2004).
  CAS Google Scholar
• Reid, R. C. et al. Countering cooperative effects in protease inhibitors using constrained beta-strand-mimicking templates in focused combinatorial libraries. J. Med. Chem. 47, 1641–1651 (2004).
  Article CAS Google Scholar
• Sodeoka, M. et al. Synthesis of a tetronic acid library focused on inhibitors of tyrosine and dual-specificity protein phosphatases and its evaluation regarding VHR and cdc25B inhibition. J. Med. Chem. 44, 3216–3222 (2001).
  Article CAS Google Scholar
• Stahura, F. L., Xue, L., Godden, J. W. & Bajorath, J. Molecular scaffold-based design and comparison of combinatorial libraries focused on the ATP-binding site of protein kinases. J. Mol. Graph Model 17, 1–9, 51–2 (1999).
  Article CAS Google Scholar
• Burke, M. D. & Schreiber, S. L. A planning strategy for diversity-oriented synthesis. Angew. Chem. Int. Edn Engl. 43, 46–58 (2004).
  Article Google Scholar
• Spring, D. R. Diversity-oriented synthesis; a challenge for synthetic chemists. Org. Biomol. Chem. 1, 3867–3870 (2003).
  Article CAS Google Scholar
• Kubota, H., Lim, J., Depew, K. M. & Schreiber, S. L. Pathway development and pilot library realization in diversity-oriented synthesis: exploring Ferrier and Pauson-Khand reactions on a glycal template. Chem. Biol. 9, 265–276 (2002).
  Article CAS Google Scholar
• Couve-Bonnaire, S., Chou, D. T., Gan, Z. & Arya, P. A solid-phase, library synthesis of natural-product-like derivatives from an enantiomerically pure tetrahydroquinoline scaffold. J. Comb. Chem. 6, 73–77 (2004).
  Article CAS Google Scholar
• Arya, P., Wei, C. Q., Barnes, M. L. & Daroszewska, M. A solid phase library synthesis of hydroxyindoline-derived tricyclic derivatives by Mitsunobu approach. J. Comb. Chem. 6, 65–72 (2004).
  Article CAS Google Scholar
• Kauvar, L. M., Villar, H. O., Sportsman, J. R., Higgins, D. L. & Schmidt, D. E. J. Protein affinity map of chemical space. J. Chromatog. B 715, 93–102 (1998).
  Article CAS Google Scholar
• Greenbaum, D. C. et al. Small molecule affinity fingerprinting. A tool for enzyme family subclassification, target identification, and inhibitor design. Chem. Biol. 9, 1085–1094 (2002).
  Article CAS Google Scholar
• Weinstein, J. N. et al. An information-intensive approach to the molecular pharmacology of cancer. Science 275, 343–349 (1997).
  Article CAS Google Scholar
• Lakey, J. H. & Raggett, E. M. Measuring protein–protein interactions. Curr. Opin. Struct. Biol. 8, 119–123 (1998).
  Article CAS Google Scholar
• Gray, N. S. et al. Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors. Science 281, 533–538 (1998).
  Article ADS CAS Google Scholar
• Salemme, F. R. Chemical genomics as an emerging paradigm for postgenomic drug discovery. Pharmacogenomics 4, 257–267 (2003).
  Article CAS Google Scholar
• MacBeath, G., Koehler, A. N. & Schreiber, S. L. Printing small molecules as microarrays and detecting protein–ligand interactions en masse. J. Am. Chem. Soc. 121, 7967–7968 (1999).
  Article CAS Google Scholar
• Winssinger, N., Ficarro, S., Schultz, P. G. & Harris, J. L. Profiling protein function with small molecule microarrays. Proc. Natl Acad. Sci. USA 99, 11139–11144 (2002).
  Article ADS CAS Google Scholar
• Falsey, J. R., Renil, M., Park, S., Li, S. & Lam, K. S. Peptide and small molecule microarray for high throughput cell adhesion and functional assays. Bioconjug. Chem. 12, 346–353 (2001).
  Article CAS Google Scholar
• Vetter, D. Chemical microarrays, fragment diversity, label-free imaging by plasmon resonance—a chemical genomics approach. J. Cell Biochem. 39 (suppl.), 79–84 (2002).
  Article Google Scholar
• Birkert, O., Tunnemann, R., Jung, G. & Gauglitz, G. Label-free parallel screening of combinatorial triazine libraries using reflectometric interference spectroscopy. Anal. Chem. 74, 834–840 (2002).
  Article CAS Google Scholar
• Birkert, O. & Gauglitz, G. Development of an assay for label-free high-throughput screening of thrombin inhibitors by use of reflectometric interference spectroscopy. Anal. Bioanal. Chem. 372, 141–147 (2002).
  Article CAS Google Scholar
• Jona, G. & Snyder, M. Recent developments in analytical and functional protein microarrays. Curr. Opin. Mol. Ther. 5, 271–277 (2003).
  CAS PubMed Google Scholar
• MacBeath, G. Protein microarrays and proteomics. Nature Genet. 32 (suppl.), 526–532 (2002).
  Article CAS Google Scholar
• Zhu, H. et al. Global analysis of protein activities using proteome chips. Science 293, 2101–2105 (2001).
  Article ADS CAS Google Scholar
• Espejo, A., Cote, J., Bednarek, A., Richard, S. & Bedford, M. T. A protein-domain microarray identifies novel protein-protein interactions. Biochem. J. 367, 697–702 (2002).
  Article CAS Google Scholar
• Newman, J. R. & Keating, A. E. Comprehensive identification of human bZIP interactions with coiled-coil arrays. Science 300, 2097–2101 (2003).
  Article ADS CAS Google Scholar
• Ziauddin, J. & Sabatini, D. M. Microarrays of cells expressing defined cDNAs. Nature 411, 107–110 (2001).
  Article ADS CAS Google Scholar
• Ramachandran, N. et al. Self-assembling protein microarrays. Science 305, 86–90 (2004).
  Article ADS CAS Google Scholar
• Lefurgy, S. & Cornish, V. Finding Cinderella after the ball: a three-hybrid approach to drug target identification. Chem. Biol. 11, 151–153 (2004).
  CAS PubMed Google Scholar
• Liberles, S. D., Diver, S. T., Austin, D. J. & Schreiber, S. L. Inducible gene expression and protein translocation using nontoxic ligands identified by a mammalian three-hybrid screen. Proc. Natl Acad. Sci. USA 94, 7825–7830 (1997).
  Article ADS CAS Google Scholar
• Lunn, M. R. et al. Indoprofen upregulates the survival motor neuron protein through a cyclooxygenase-independent mechanism. Chem. Biol. 11, 1495–1503 (2004).
  Article Google Scholar
• Dolma, S., Lessnick, S. L., Hahn, W. C. & Stockwell, B. R. Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell 3, 285–296 (2003).
  Article CAS Google Scholar
• Wang, J. & Dreyfuss, G. A cell system with targeted disruption of the SMN gene: functional conservation of the SMN protein and dependence of Gemin2 on SMN. J. Biol. Chem. 276, 9599–9605 (2001).
  Article CAS Google Scholar
• Aiken, C. T., Tobin, A. J. & Schweitzer, E. S. A cell-based screen for drugs to treat Huntington's disease. Neurobiol. Dis. 16, 546–555 (2004).
  Article CAS Google Scholar
• Stegmaier, K. et al. Gene expression-based high-throughput screening(GE-HTS) and application to leukaemia differentiation. Nature Genet. 36, 257–263 (2004).
  Article CAS Google Scholar
• Kapur, R. Fluorescence imaging and engineered biosensors: functional and activity-based sensing using high content screening. Ann. NY Acad. Sci. 961, 196–197 (2002).
  Article ADS Google Scholar
• Yarrow, J. C., Perlman, Z. E., Westwood, N. J. & Mitchison, T. J. A high-throughput cell migration assay using scratch wound healing, a comparison of image-based readout methods. BMC Biotechnol. 4, 21 (2004).
  Article Google Scholar
• Kau, T. R. et al. A chemical genetic screen identifies inhibitors of regulated nuclear export of a Forkhead transcription factor in PTEN-deficient tumor cells. Cancer Cell 4, 463–476 (2003).
  Article CAS Google Scholar
• Root, D. E., Flaherty, S. P., Kelley, B. P. & Stockwell, B. R. Biological mechanism profiling using an annotated compound library. Chem. Biol. 10, 881–892 (2003).
  Article CAS Google Scholar
• Seidler, J., McGovern, S. L., Doman, T. N. & Shoichet, B. K. Identification and prediction of promiscuous aggregating inhibitors among known drugs. J. Med. Chem. 46, 4477–4486 (2003).
  Article CAS Google Scholar
• Tuschl, T. Expanding small RNA interference. Nature Biotechnol. 20, 446–448 (2002).
  Article CAS Google Scholar
• Elbashir, S. M. et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494–498 (2001).
  Article ADS CAS Google Scholar
• Lassus, P., Rodriguez, J. & Lazebnik, Y. Confirming specificity of RNAi in mammalian cells. Sci. STKE 147, PL13 (2002).
  Google Scholar
• Root, D. E., Kelley, B. P. & Stockwell, B. R. Global analysis of large-scale chemical and biological experiments. Curr. Opin. Drug Discov. Dev. 5, 355–360 (2002).
  CAS Google Scholar
• Burke, T. J., Loniello, K. R., Beebe, J. A. & Ervin, K. M. Development and application of fluorescence polarization assays in drug discovery. Comb. Chem. High Throughput Screen. 6, 183–194 (2003).
  Article CAS Google Scholar
• Timasheff, S. N., Andreu, J. M. & Na, G. C. Physical and spectroscopic methods for the evaluation of the interactions of antimitotic agents with tubulin. Pharmacol. Ther. 52, 191–210 (1991).
  Article CAS Google Scholar
• Bulseco, D. A. & Wolf, D. E. Fluorescence correlation spectroscopy: molecular complexing in solution and in living cells. Methods Cell Biol. 72, 465–498 (2003).
  Article Google Scholar
• Misra, R. Modern drug development from traditional medicinal plants using radioligand receptor-binding assays. Med. Res. Rev. 18, 383–402 (1998).
  Article CAS Google Scholar
• Hicks, R. P. Recent advances in NMR: expanding its role in rational drug design. Curr. Med. Chem. 8, 627–650 (2001).
  Article CAS Google Scholar
• Siegel, M. M. Early discovery drug screening using mass spectrometry. Curr. Top. Med. Chem. 2, 13–33 (2002).
  Article CAS Google Scholar
• Homola, J. Present and future of surface plasmon resonance biosensors. Anal. Bioanal. Chem. 377, 528–539 (2003).
  Article CAS Google Scholar
• Jelesarov, I. & Bosshard, H. R. Isothermal titration calorimetry and differential scanning calorimetry as complementary tools to investigate the energetics of biomolecular recognition. J. Mol. Recogn. 12, 3–18 (1999).
  Article CAS Google Scholar
• Burke, M. D., Berger, E. M. & Schreiber, S. L. Generating diverse skeletons of small molecules combinatorially. Science 302, 613–618 (2003).
  Article ADS CAS Google Scholar
• Oprea, T. I. & Matter, H. Integrating virtual screening in lead discovery. Curr. Opin. Chem. Biol. 8, 349–358 (2004).
  Article CAS Google Scholar
• Ewing, T. J., Makino, S., Skillman, A. G. & Kuntz, I. D. DOCK 4.0: search strategies for automated molecular docking of flexible molecule databases. J. Comput. Aided Mol. Des. 15, 411–428 (2001).
  Article ADS CAS Google Scholar
• Osterberg, F., Morris, G. M., Sanner, M. F., Olson, A. J. & Goodsell, D. S. Automated docking to multiple target structures: incorporation of protein mobility and structural water heterogeneity in AutoDock. Proteins 46, 34–40 (2002).
  Article CAS Google Scholar
• Kramer, B., Rarey, M. & Lengauer, T. Evaluation of the FLEXX incremental construction algorithm for protein-ligand docking. Proteins 37, 228–241 (1999).
  Article CAS Google Scholar
• Halgren, T. A. et al. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J. Med. Chem. 47, 1750–1759 (2004).
  Article CAS Google Scholar
• Vangrevelinghe, E. et al. Discovery of a potent and selective protein kinase CK2 inhibitor by high-throughput docking. J. Med. Chem. 46, 2656–2662 (2003).
  Article CAS Google Scholar
• Peng, H. et al. Identification of novel inhibitors of BCR-ABL tyrosine kinase via virtual screening. Bioorg. Med. Chem. Lett. 13, 3693–3699 (2003).
  Article CAS Google Scholar
• Bajorath, J. Integration of virtual and high-throughput screening. Nature Rev. Drug Discov. 1, 882–894 (2002).
  Article CAS Google Scholar
• Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46, 3–26 (2001).
  Article CAS Google Scholar
• Hann, M. M. & Oprea, T. I. Pursuing the leadlikeness concept in pharmaceutical research. Curr. Opin. Chem. Biol. 8, 255–263 (2004).
  Article CAS Google Scholar